AnHeart Therapeutics
AnHeart Therapeutics is an orally available small molecule founded in 2018 by Lihua Zheng.
1
Funding Rounds
$61.0m
Money raised
Funding series
Funding Series Analysis
The company AnHeart Therapeutics has raised a total of $61m in funding over 1 rounds.
Key Insights:
- AnHeart Therapeutics Series B round, December 2021: $61m
AnHeart Therapeutics Series B round, December 2021
$61m
Industries
AnHeart Therapeutics is active in the following industries:
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Engineering